These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7469497)

  • 1. [The effects of diphenylhydantoin and spironolactone on the digoxin pharmacokinetics in the rabbit (author's transl)].
    Tato F; Pérez Fontán J; Lloveres J
    Arch Farmacol Toxicol; 1980 Aug; 6(2):151-60. PubMed ID: 7469497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of temperature on the kinetics of propranolol, theophylline, phenytoin and digoxin in rats (author's transl)].
    Albin H; Vincon G; Ploux D; Dangoumau J
    J Pharmacol; 1981; 12(3):229-38. PubMed ID: 7289622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients.
    DiPiro JT; Cote JR; DiPiro CR; Bustrack JA
    Am J Hosp Pharm; 1980 Nov; 37(11):1518-21. PubMed ID: 7211855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
    Huffman DH
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):787-90. PubMed ID: 4477402
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone-induced changes in digoxin kinetics.
    Waldorff S; Andersen JD; Heebøll-Nielsen N; Nielsen OG; Moltke E; Sørensen U; Steiness E
    Clin Pharmacol Ther; 1978 Aug; 24(2):162-7. PubMed ID: 679595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pretreatment with spironolactone on pharmacokinetics of 4'''-methyldigoxin in rats.
    Abshagen U
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):91-100. PubMed ID: 4267969
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction of spironolactone and digoxin: a review and evaluation.
    Thomas RW; Maddox RR
    Ther Drug Monit; 1981; 3(2):117-20. PubMed ID: 7022769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of aminoglutethimide and spironolactone on the efficacy of carbamazepine and diphenylhydantoin against amygdala-kindled seizures in rats.
    Borowicz KK; Czuczwar SJ
    Eur J Pharmacol; 2005 Jun; 516(3):212-8. PubMed ID: 15958264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].
    Masson JP; Bass O; Baur HR; Ohnhaus EE
    Klin Wochenschr; 1978 Nov; 56(21):1071-6. PubMed ID: 713428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of stat assay of serum digoxin concentration by radioimmunoassay and its application for digoxin regimen based in pharmacokinetics (author's transl)].
    Sasaki Y; Sato A; Shinozaki K; Masuhara K; Tabuse K; Kashiwada K; Kida H; Sakaki T; Arai S; Someya K
    Radioisotopes; 1980 Sep; 29(9):432-7. PubMed ID: 7221021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of diphenylhydantoin sodium on the in vivo electroretinogram of rabbits (author's transl)].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 1975 Apr; 79(4):227-32. PubMed ID: 1170722
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of spironolactone on excretion of 3H-digoxin and its metabolites in rats.
    Wirth KE; Frölich JC
    Eur J Pharmacol; 1974 Nov; 29(1):43-51. PubMed ID: 4435043
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of phenytoin on the tissue concentrations of digoxin in the rat.
    Allonen H
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):481-8. PubMed ID: 579559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of digoxin dosage regimen.--Application of pharmacokinetics and digoxin stat assay by radioimmunoassay (author's transl)].
    Masuhara K; Shinozaki K; Nozaki H; Sasaki Y; Kashiwada K; Kida H; Sato A; Sakaki T; Arai S; Someya K
    Yakugaku Zasshi; 1981 Jan; 101(1):82-5. PubMed ID: 7252788
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: The influence of spironolactone on the excretion and metabolism of 3H-digoxin in the rat.
    Wirth KE; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R107. PubMed ID: 4276675
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of therapeutic doses of spironolactone on the liver microsomal enzyme system and digoxin elimination in man [proceedings].
    Ohnhaus EE; Masson JP
    Br J Clin Pharmacol; 1977 Oct; 4(5):639P-640P. PubMed ID: 911625
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between digoxin and potassium-sparing diuretics.
    Waldorff S; Hansen PB; Egeblad H; Berning J; Buch J; Kjaergård H; Steiness E
    Clin Pharmacol Ther; 1983 Apr; 33(4):418-23. PubMed ID: 6831820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioavailability of digoxin in fixed combinations (author's transl)].
    Ochs H; Bodem G; Dengler HJ
    Klin Wochenschr; 1974 Jul; 52(13):637-9. PubMed ID: 4848130
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of oral digoxin. Influence of congestive heart failure and age of patients (author's transl)].
    Scherrmann JM; Venet R; Memin Y; Bourdon R
    Therapie; 1981; 36(2):169-78. PubMed ID: 7292391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.